Skip to main content

Table 3 Median and range for ICIQ NQol by treatment with p-value and standardized effect size, d

From: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Measure Treatment
A: Placebo B: Melatonin p d
Median Range Median Range
Overall score 25.0 8–35 20.0 8–42 0.341 0.261
Overall interference 5.0 0–9 4.0 0–9 0.444 0.209
Sleep/Energy sub-score 11.0 3–19 10.0 3–18 0.549 0.164
Bother/Concern sub-score 9.5 4–21 9.0 3–16 0.288 0.292